Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythrocyte digoxin concentration

S Kawai, K Ogawa, T Satake

    Clinical Pharmacology and Therapeutics
    |May 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Erythrocyte digoxin levels may help differentiate between toxic and nontoxic drug concentrations in patients undergoing maintenance therapy. This finding aids in monitoring digoxin therapy and preventing adverse effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Hormone therapy using tamoxifen in unresectable carcinoma of the pancreas--preliminary study].

    Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
    Same author

    Histological pancreatitis in end-stage renal disease.

    International journal of pancreatology : official journal of the International Association of Pancreatology·1992
    Same author

    Bioavailability study of commercial sustained-release preparations of diclofenac sodium in gastrointestinal physiology regulated-dogs.

    Chemical & pharmaceutical bulletin·1992
    Same author

    Alternatively-spliced p53 mRNA in the FAA-HTC1 rat hepatoma cell line without the splice site mutations.

    Cell structure and function·1992
    Same author

    A three-dimensional observation of acid phosphatase-positive structures in rat testis by high voltage electron microscopy.

    Okajimas folia anatomica Japonica·1992
    Same author

    Retroviral-mediated gene transfer to neonatal rat hepatocytes and intrasplenic transplantation of the transduced hepatocytes.

    Transplantation proceedings·1992
    Same journal

    Epcoritamab Step-Up Dosing Regimen Selection and Optimization Using Repeated Time-to-Event Modeling for Cytokine Release Syndrome Risk Mitigation.

    Clinical pharmacology and therapeutics·2026
    Same journal

    From Executor to Orchestrator: The Pharmacology Scientist in the Age of Agentic AI.

    Clinical pharmacology and therapeutics·2026
    Same journal

    The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Effects of Trimethoprim on Three Previously Proposed Putative Biomarkers for OCT2/MATE-Mediated Renal Drug-Drug Interactions in Healthy Volunteers.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Clinical Characterization of Enzyme and Transporter Precipitants to Evaluate Drug-Drug Interactions for Orforglipron, a Small Molecule Glucagon-Like Peptide-1 Receptor Agonist.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Symposium Report: Stakeholders' Perspectives on Phase 1 Trials in Japanese Prior to Multi-Regional Clinical Trials and Future Pathways.

    Clinical pharmacology and therapeutics·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Clinical Chemistry
    • Toxicology

    Background:

    • Digoxin is a cardiac glycoside used for heart failure and arrhythmias.
    • Monitoring digoxin levels is crucial due to its narrow therapeutic index.
    • Distinguishing between therapeutic and toxic levels can be challenging.

    Purpose of the Study:

    • To compare plasma and erythrocyte digoxin concentrations in patients with toxic versus nontoxic drug levels.
    • To investigate digoxin accumulation and release in both plasma and erythrocytes.
    • To determine the utility of erythrocyte digoxin levels in clinical practice.

    Main Methods:

    • Measurement of plasma and erythrocyte digoxin concentrations.
    • Comparison of drug levels between toxic and nontoxic patient groups.

    Related Experiment Videos

  • Study of digoxin dynamics (cumulation and release).

    • Main Results:

    • Significant differences observed in erythrocyte digoxin concentrations between toxic and nontoxic groups.
    • Erythrocyte digoxin levels showed potential in differentiating toxicity.
    • Digoxin accumulation and release patterns were analyzed in both compartments.

    Conclusions:

    • Erythrocyte digoxin concentration is a potentially valuable biomarker for assessing digoxin toxicity.
    • This method may improve the accuracy of therapeutic drug monitoring for digoxin.
    • Further validation is warranted to integrate this into routine clinical practice.